We're excited to announce our partnership with Offspring Biosciences!

We're a Gold Sponsor for Spatial Biology East Coast Congress, June 10-11 in Boston.

We're exhibiting at the 14th World Clinical Biomarkers & CDx Summit Sept. 4-6 in Boston.

SPATIALPlexSOLUTIONS

AN INNOVATIVE APPROACH TO YOUR BIOMARKER AND CLINICAL DEVELOPMENT PROGRAM

DEFINE, DEVELOP, EXECUTE

Since 2009, we’ve led the way in spatial biology, being among the first to utilize machine learning and AI for spatial analysis and establishing ourselves as the most dependable partner for your clinical program.

Spatially visualizing drug activity with unparalleled precision, Flagship Biosciences supports discovery and target engagement decisions that transcend conventional approaches, enabling vivid insights to refine drug efficacy. 

Flagship Biosciences is proud to be a CLIA-certified and CAP-accredited laboratory. This demonstrates our commitment to maintaining the highest standards of quality and accuracy in laboratory testing and analysis.

ADVANCING YOUR
BIOMARKER PROGRAM

In rare disease, oncology and other therapeutic areas, Flagship can develop, validate and operationalize complex assays.

Flagship has an extensive library  of validated singleplex, duplex and multiplex panels for client use.

FLAGSHIP DATA SCIENCE

Streamline spatial analysis through the power of AI with a consultative approach

Our approach involves collecting and analyzing over a thousand data points per cell, employing a combination of proprietary and open-source data analysis tools. With the expertise of our seasoned Data Science Team, we provide insightful answers that inform critical decisions in therapeutic development. Our method seamlessly integrates results derived from spatial proteomic and genomic data, enhancing the depth and breadth of our analyses.

We're excited to announce our partnership with Offspring Biosciences!

We're a Gold Sponsor for Spatial Biology East Coast Congress, June 10-11 in Boston.

We're exhibiting at the 14th World Clinical Biomarkers & CDx Summit Sept. 4-6 in Boston.

ADVANCING YOUR BIOMARKER PROGRAM

In rare disease, oncology and other therapeutic areas, Flagship can develop, validate and operationalize complex assays.

Flagship has an extensive library  of validated singleplex, duplex and multiplex panels for client use.

FLAGSHIP DATA SCIENCE

Streamline spatial analysis through the power of AI with a consultative approach

Our approach involves collecting and analyzing over a thousand data points per cell, employing a combination of proprietary and open-source data analysis tools. With the expertise of our seasoned Data Science Team, we provide insightful answers that inform critical decisions in therapeutic development. Our method seamlessly integrates results derived from spatial proteomic and genomic data, enhancing the depth and breadth of our analyses.

Spatial Biology Expertise

Guiding Translational Decisions

SPATIALPlex SOLUTIONS – Flagship’s spatial biology platform is comprised of an integrated team of scientists, cutting edge bioinformaticians and a legacy of pathology expertise.

With seventeen US patents backing our proprietary image analysis technology, Flagship partners with you to deliver customized data to meet your unique needs. Starting with assessment and determining the correct modalities, our dedicated and collaborative scientific and project management teams provide end-to-end support throughout the entire process, from pre-IND to commercialization.

Multiplex IHC and In Situ Hybridization are powerful diagnostic tools that enable the simultaneous detection of multiple biomarkers in a single sample. Flagship Biosciences offers a comprehensive service that includes the development, validation, and execution of multiplex IHC, FISH, and CISH assays that can detect up to six biomarkers per sample. Our state-of-the-art technology and expertise in the field enable us to provide accurate and reliable results that can help inform clinical decisions and support drug development programs. With Flagship Biosciences, you can trust that your multiplex assays are in the hands of experienced professionals who are dedicated to delivering the highest quality service possible.

LEARN MORE

Flagship provides a range of genomic analysis services that encompass various techniques and applications. Our team of experts is well-equipped and proficient in handling diverse forms of genomic analysis, including full genome sequencing, RNA sequencing, spatial transcriptomics, and methylation sequencing. We utilize state-of-the-art technologies and advanced methods to ensure that our results are accurate and reliable. Furthermore, our molecular extraction capabilities are robust, allowing us to work with a diverse range of sample types and formats. Whether you are engaged in basic research or drug development, our genomics services offer valuable insights to help you achieve your goals. You can trust Flagship Biosciences to offer the highest quality results and support for all your genomic analysis needs.

LEARN MORE

Our scientific and medical teams are experienced in flow cytometry assessments supporting many applications including hematopoietic neoplasms, MRD, receptor occupancy, expansive immunophenotyping, and Immuno-oncology assessments. 

LEARN MORE

Flagship Biosciences has developed a state-of-the-art digital pathology and image analysis department that is staffed by a team of highly skilled professionals. Our experts utilize our proprietary artificial intelligence software, Flotilla, to create customized deep-learning solutions that cater to your target disease states and biomarkers. 

Our capable data science group specializes in sophisticated multi-omic projects. We possess the expertise required to seamlessly integrate disparate data sets into holistic conclusions that offer valuable insights for your research project. We utilize advanced methodologies and cutting-edge technology to deliver the comprehensive and accurate answers your program requires.

LEARN MORE